Search by Ticker
Spdr Series Trust Spdr S&p Bio (NYSEArca:XBI)
The following stock analysis is based on 7.4 years of data (i.e. since Feb 25, 2013). All the stock history has been downloaded.
Spdr Series Trust Spdr S&p Bio trades on the NYSEArca exchange in USD dollars.
It is in the sector.
It is currently trading at $113.92 ($109.33 the previous day).
The current Canada / US exchange rate is 1.3387.
The year over year average increase is 5.3% per year assuming steady exponential growth. The actual 5 year average is 6.4. Details on the individual increase in one year intervals is provided below.
|Past Performance||Average Price||Percent Change|
|1 year||87.803537414966||2.2||- Below Average|
|2 year||85.906048387097||-3.4||- Below Average|
|3 year||88.893305439331||31.2||+ Above Average|
|4 year||67.756408163265||10.6||+ Above Average|
|5 year||61.273333333333||-8.6||- Below Average|
The worst drop it has had in recent years is -49.4%. It has a shape to the stock curve, which means
Biotech IPOs Capture Record $7.5 Billion in Second QuarterThu, 23 Jul 2020 20:42:25 The popularity of the sector continues with 57 new companies on tap to go public Continue reading...... Read Full Article
ETF Areas for July as Second Wave of Coronavirus Hits HardTue, 30 Jun 2020 20:47:08 As the COVID-19 outbreak continues to aggravate in the United States, we discuss some ETF areas that investors can consider for investing in July.... Read Full Article
New Pharma ETF Focuses on Testing and Treatment for Infectious Diseases--but Not Covid-19Sun, 28 Jun 2020 20:51:05 GERM offers investors exposure to established providers and ‘unsung heroes’ of biotech and life sciences Continue reading...... Read Full Article
Try These ETF Areas in Virus-Impacted Second Half of 2020Wed, 24 Jun 2020 21:55:09 Here we highlight a few ETF areas that have the potential to do well in the second half of this year amid the coronavirus crisis.... Read Full Article
Biotech Stocks Are Getting Ready to Run. How to Play It.Sat, 20 Jun 2020 13:48:00 Given the amount of attention paid to Covid-19 treatments and vaccines, it would be easy to assume that all of the good news was already reflected in biotech stocks. That’s not quite the case.... Read Full Article
Best ETF Ideas for the Second Half of 2020Thu, 11 Jun 2020 20:07:08 We discuss how investors should position their portfolios for the new normal.... Read Full Article
Biotech Funds Testing Multi-Year ResistanceTue, 09 Jun 2020 13:55:44 Biotech funds are testing their 2015 highs, setting the stage for a major breakout or painful reversal.... Read Full Article
These ETF Areas Make Great Investment Choices in JuneTue, 02 Jun 2020 20:55:08 Here we highlight some ETF areas that will make interesting investment options for investors amid the coronavirus crisis.... Read Full Article
Why virus stocks are driving market volatilityMon, 01 Jun 2020 12:03:00 The market’s erratic response to lukewarm medical research for COVID-19 treatment and vaccine candidates isn’t expected to slow down as investors pin their hopes for an economic recovery on the high-risk biotechnology sector.... Read Full Article
Biotech ETFs Are Soaring. These Four Are Still Worth Considering.Mon, 01 Jun 2020 12:00:00 Investors have been bullish on biotech, in the hope that companies will soon come up with a treatment, cure, or vaccine for Covid-19. But there’s more to biotech than the coronavirus, and even though these ETFs have risen, they ...... Read Full Article
Telehealth is going to and'become the defaultand' for patients: Ro CEOFri, 22 May 2020 11:46:27 Telehealth companies enabling individuals to see physicians without stepping foot into a physical doctor’s office are having their moment, as the coronavirus pandemic confines individuals and would-be patients across the country largely to their homes.... Read Full Article
3 Charts That Suggest Biotech Stocks Are Headed HigherWed, 20 May 2020 17:30:14 Breakouts beyond key levels of resistance suggest that the bulls are in control of the momentum in the biotech sector.... Read Full Article
Moderna COVID-19 vaccine data is ‘baby-step’ in right direction: ExpertMon, 18 May 2020 18:47:12 Professor of Medicine at Yale and Director of The Yale New Haven Hospital Center for Outcomes Research and Evaluation Dr. Harlan Krumholz joins Yahoo Finance’s Seana Smith to discuss Moderna’s recent headway in an early-stage coronavirus vaccine trial.... Read Full Article
Biotech ETFs trade higher on upbeat coronavirus resultsMon, 18 May 2020 14:51:00 Biotechnology-themed exchange-traded funds surged higher late Monday morning as investors rewarded pharmaceutical companies that looked likely to profit from treatments for COVID-19. The SPDR SandP Biotech ETF was up 3.1%, and the iShares NASDAQ Biotechnology ETF gained more than 2%. Two funds ...... Read Full Article
3 ETFs in Focus as Race for Vaccine IntensifiesMon, 18 May 2020 14:03:51 Several companies sit at the forefront of developing a coronavirus vaccine. Gain exposure to each using the following three ETFs.... Read Full Article
What’s the most shorted sector? The answer might surprise youSat, 16 May 2020 17:34:00 Will markets go up or down as we move toward summer? No one knows for sure, but one metric to watch is activity among short sellers — investors who believe a particular security will decline in value.... Read Full Article
Cassava stock falls on failed Alzheimerand's studyFri, 15 May 2020 15:31:00 Shares of Cassava Sciences Inc. tumbled 73.2% in trading on Friday after the company said its investigational Alzheimerand's disease treatment failed a mid-stage trial. The experimental drug, PTI-125, did not meet the primary endpoint (reducing cerebrospinal fluid (CSF) levels of tau ...... Read Full Article
ETF Short Sellers Are Targeting Retail, BiotechWed, 13 May 2020 16:31:02 The SandP 50o has come roaring back in the past two months, but there are still plenty of skeptics when it comes to the recent rally.There is currently $168.2 billion in aggregate domestic ETF short interest, according to S3 Partners ...... Read Full Article
Biotech Funds Could Rally to New HighsFri, 08 May 2020 15:05:11 Biotech funds have rallied within striking distance of multi-year resistance and could break out in coming weeks.... Read Full Article
Stocks surge as more states move to reopen amid coronavirusTue, 05 May 2020 19:11:46 JP Morgan Private Bank Head of Cross-Asset Thematic Strategy Anastasia Amoroso joins Yahoo Finance’s Seana Smith to discuss the latest market action as more states move to reopen their economies in the wake of the coronavirus. ... Read Full Article